I agree with you Mozz. We still have to try to improve our bargaining position with BP or for that matter MP. The only way we are going to do that is to at least get 002 and 003 underway and hopefully through to completion and readout. Because of poor cost projections and CR bungles, we are in this present precarious position. I forecast a year or 2 ago we would have circa 500 M shares on issue before we gain regulatory approval from FDA. Looks like I have been a little conservative.
Say the present circa 350 M shares, blows out to 700-800M, I don’t think it is a tragedy. Bad case scenario (not worst case) we raise another $80M @ 20c. We may well be able to do a bit better then that. That should surely see us through to a partnership that we have negotiated on good terms for us.
I still think despite the dilution, that our share price has a great chance of many multiples of the present. Good luck to us all.
PAR Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)